Pin Guo, Huanting Li, Chengzhan Zhu, Xinjuan Kong, Yugong Feng, Wei Liu, Shifang Li, Zhaojian Li, Kun Han, Weicheng Yao, Yingying Lin, Yongming Qiu, Yanan Yu
Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
Institute of Cerebral Vascular Diseases, The Affiliated Hospital of Qingdao University, Qingdao, China.
Front Cell Dev Biol. 2020 Nov 12;8:593685. doi: 10.3389/fcell.2020.593685. eCollection 2020.
The programmed cell death 4 () tumor-suppressor gene regulates cell apoptosis, protein translation, signal transduction, and induction of mediators of inflammation. However, the mechanism by which is down-regulated and regulates tumor growth remains elusive. In this study, we showed that PDCD4 is down-regulated in glioma cells and acts as a tumor suppressor. Based on the TCGA data, we confirmed that AKT2, but not AKT1 or AKT3, interacts with PDCD4, thus leading to the suppression of PDCD4 in glioma cells. Moreover, the analysis suggested that PDCD4 regulates the expression of IL-5, CCL-5, VEGF, and CXCL10 via the NF-kB pathway. Additionally, depletion of levels of promoted angiogenic activity of glioma cells via the VEGF-STAT3 pathway. When tumor cells over-expressing were injected into nude mice, the increased expression of PDCD4 blocked tumorigenesis and prolonged overall survival. Our study indicates the need to develop drugs that can modulate the expression of PDCD4 and test their efficacy in clinical trials.
程序性细胞死亡4(PDCD4)肿瘤抑制基因调节细胞凋亡、蛋白质翻译、信号转导以及炎症介质的诱导。然而,PDCD4下调并调节肿瘤生长的机制仍不清楚。在本研究中,我们表明PDCD4在胶质瘤细胞中下调并作为肿瘤抑制因子发挥作用。基于TCGA数据,我们证实是AKT2而非AKT1或AKT3与PDCD4相互作用,从而导致胶质瘤细胞中PDCD4受到抑制。此外,分析表明PDCD4通过NF-κB途径调节IL-5、CCL-5、VEGF和CXCL10的表达。另外,PDCD4水平的降低通过VEGF-STAT3途径促进了胶质瘤细胞的血管生成活性。当将过表达PDCD4的肿瘤细胞注射到裸鼠体内时,PDCD4表达的增加阻断了肿瘤发生并延长了总体生存期。我们的研究表明需要开发能够调节PDCD4表达的药物并在临床试验中测试其疗效。